Leadership
EXECUTIVE TEAM
Antony Rabar, Chairman and CEO
Tony is a successful serial entrepreneur with over 25 years of involvement in early-stage technology startups and commercialization. He has worked across multiple technologies and industries, from the factory floor to advising listed company boards of directors.
Tony has a strong record of creating value and returning profits to investors. In 2015, he formed a VC fund backed by the government of South Korea focused on commercializing novel med-tech developed in the UK’s NHS. To date, four of the eight investments have IPO’d with approximately total market valuation at the launch of $1 billion, and the fund is returning a remarkable 2.5x cash-on-cash in eight years.
Tony has a strong record of creating value and returning profits to investors. In 2015, he formed a VC fund backed by the government of South Korea focused on commercializing novel med-tech developed in the UK’s NHS. To date, four of the eight investments have IPO’d with approximately total market valuation at the launch of $1 billion, and the fund is returning a remarkable 2.5x cash-on-cash in eight years.
As a founding investor of T&CT in 2011, Tony’s commitment to the company is unwavering. He took on the role of Chairman & CEO in late 2017, and has since successfully steered the company through both the covid and Brexit crises. His leadership has been instrumental in launching T&CT’s EU operations in Europe, USA and Middle East, where it has established commercial relations and collaborations with 30+ leading reconstructive and regenerative medicine centers.
Tony holds degrees in Law and Business from the University of Melbourne and an MBA from the University of Virginia.
David Haddow, Chief Technology Officer
David has a particular interest in tissue and cell therapies, with a successful track record in overcoming the challenges of translational medicine to bring four products to market in the plastic and reconstructive surgery sector.
David has a Ph.D from The University of Sheffield and completed his postgraduate tissue engineering research.
David was an early leader, serving as the industrial panel representative on the Medical Research Council’s Regenerative Medicine Research Committee and as a panel member for the Human Tissue Authority Stakeholder and Fees Group.
David has a Ph.D from The University of Sheffield and completed his postgraduate tissue engineering research.
David was an early leader, serving as the industrial panel representative on the Medical Research Council’s Regenerative Medicine Research Committee and as a panel member for the Human Tissue Authority Stakeholder and Fees Group.
Dick van Kalkeren, General Manager, Europe
Dick brings 18 years of experience in medical products and services in the EU focused on the plastic surgery sector.
Dick counts over 400 plastic surgeons in his immediate network across the EU; all developed out of his previous plastic surgery products business.
He has direct experience selling established products and inception of novel products and reimbursement regimes in each country.
Dick counts over 400 plastic surgeons in his immediate network across the EU; all developed out of his previous plastic surgery products business.
He has direct experience selling established products and inception of novel products and reimbursement regimes in each country.
Special Interests:
- New Product/Service Launching
- Health Economics
- Export Management
- Regulatory Affairs
Brad Westcott, Managing Director, USA
Before joining T&CT, Brad grew two medical companies. Most recently, he was CEO and Founder of CortiCare, which provides brain monitoring (EEG) services to hospitals and home patients in the USA. Brad grew the company to over 200 hospital accounts and more than 200 workers and had a successful exit to a PE firm.
Before CortiCare, Brad was CEO of Alpine Biomed. This neuro-based medical instrument company acquired Medtronic’s neurodiagnostic division and successfully exited another healthcare company.
Brad raised over $20M to help grow these two companies. In addition to these businesses, Brad is married and has two children who have successfully escaped home, was a ranked tennis player, spent two years in the Peace Corps, and was the founding chairman at the San Diego World Trade Center.
Before CortiCare, Brad was CEO of Alpine Biomed. This neuro-based medical instrument company acquired Medtronic’s neurodiagnostic division and successfully exited another healthcare company.
Brad raised over $20M to help grow these two companies. In addition to these businesses, Brad is married and has two children who have successfully escaped home, was a ranked tennis player, spent two years in the Peace Corps, and was the founding chairman at the San Diego World Trade Center.
Blaine Hamilton, VP Commercial Operations, USA
Blaine brings 12 years of experience commercializing plastic and reconstructive surgery products in the USA to T&CT.
With a comprehensive educational background in Cell & Molecular Biology and Business Administration, Blaine has honed his skills in various areas, serving in roles of increasing responsibility in sales, sales training, medical affairs, medical education, clinical study, and product development.
Blaine brings a vast network of close relationships in reconstructive and cosmetic plastic surgery across the USA.
With a comprehensive educational background in Cell & Molecular Biology and Business Administration, Blaine has honed his skills in various areas, serving in roles of increasing responsibility in sales, sales training, medical affairs, medical education, clinical study, and product development.
Blaine brings a vast network of close relationships in reconstructive and cosmetic plastic surgery across the USA.
Monique Ramsey, Director of Marketing, USA
Monique is an accomplished and passionate leader with over 30 years of experience in the aesthetics industry. Proven ability to wear multiple hats, including creative direction, social media marketing, podcasting, and relationship building. Adept at developing and implementing strategic initiatives that enhance brand awareness, online presence, and community engagement.
Beyond leadership, Monique’s expertise lies in social media and relationship marketing. Since 2009, she has helped businesses in the medical, spa, and skincare industries leverage social media to cultivate strong online communities and achieve growth.
Monique’s passion for social media, graphic design, podcasting, and content marketing allows her to bring a fresh perspective and valuable skillset to Tissue & Cell Technologies.
Beyond leadership, Monique’s expertise lies in social media and relationship marketing. Since 2009, she has helped businesses in the medical, spa, and skincare industries leverage social media to cultivate strong online communities and achieve growth.
Monique’s passion for social media, graphic design, podcasting, and content marketing allows her to bring a fresh perspective and valuable skillset to Tissue & Cell Technologies.
BOARD OF DIRECTORS
Tony Rabar, CHAIRMAN
- (See above or write two mini bios - one focusing on his role as CEO and the other new focusing on his role on the board)
Alexander Scott-Barrett
David Atkins (?)
Brad Conlan (?)
CLINICAL ADVISORS
Professor Michael Atlan, MD, Ph.D.
Michael is the Chief of Plastic, Reconstructive, and Aesthetic Surgery at Tenôn Hospital AP-HP, Paris, and the Professor of Hospital Practice at Sorbonne University, Faculty of Medicine, France’s #1 ranked medical faculty.
As one of France’s leading academic researchers in reconstructive medicine, Michael has expertise in the role of adipose-derived regenerative cells (ADRCs).
Dr. Atlan is a founder of Campus Champs Elysee, an organization specializing in providing education and training opportunities in aesthetic surgery.
As one of France’s leading academic researchers in reconstructive medicine, Michael has expertise in the role of adipose-derived regenerative cells (ADRCs).
Dr. Atlan is a founder of Campus Champs Elysee, an organization specializing in providing education and training opportunities in aesthetic surgery.
Professor Moustapha Hamdi, MD, FCCP, PhD.
Professor Hamdi is one of the World’s leading aesthetic and reconstructive breast surgery surgeons. He heads the Department of Plastic and Reconstructive Surgery at the University Clinic of Brussels. He is a leading surgeon at the Delta Hospital — Chirec Group. His clinical expertise has led to several surgical techniques named after him.
Dr. Hamdi is an international speaker and organizer of many meetings and courses in Breast Surgery. His primary expertise is breast reconstruction, and he has contributed to many books and chapters concerning Aesthetic Breast Surgery. He is the former President of the Royal Belgian Society for Plastic Surgery (RBSPS), a member of the Belgian Board of Plastic Surgery, and an expert member of the high council of the Ministry of Health in Belgium. He is also very active on the scientific committee of the European Society of Plastic Surgeons (EURAPS)
Dr. Hamdi is an international speaker and organizer of many meetings and courses in Breast Surgery. His primary expertise is breast reconstruction, and he has contributed to many books and chapters concerning Aesthetic Breast Surgery. He is the former President of the Royal Belgian Society for Plastic Surgery (RBSPS), a member of the Belgian Board of Plastic Surgery, and an expert member of the high council of the Ministry of Health in Belgium. He is also very active on the scientific committee of the European Society of Plastic Surgeons (EURAPS)
Professor J. Peter Rubin, MD, FACS
Dr. Rubin is the Chair of the Department of Plastic Surgery at the University of Pittsburgh Medical Centre (UPMC), the UPMC Endowed Professor of Plastic Surgery, Director of UPMC Wound Healing Services, and Professor of Bioengineering at the University of Pittsburgh.
He is the founder and past President of the International Fat Applied Technology Society (IFATS), founder of the Center for Innovation in Restorative Medicine (CIRM), and advisor to the US Department of Defense (DOD) Office of Technology Transition-sponsored research on soft tissue regeneration and scar contracture.
Dr. Rubin leads a fundamental research program focused on the biology of adipose-derived stem cells. He also co-directs the Adipose Stem Cell Center at the University of Pittsburgh. Additionally, Dr. Rubin is the primary investigator on an NIH-funded project dedicated to creating cell-based techniques for clinical soft tissue reconstruction following cancer treatment.
He is the founder and past President of the International Fat Applied Technology Society (IFATS), founder of the Center for Innovation in Restorative Medicine (CIRM), and advisor to the US Department of Defense (DOD) Office of Technology Transition-sponsored research on soft tissue regeneration and scar contracture.
Dr. Rubin leads a fundamental research program focused on the biology of adipose-derived stem cells. He also co-directs the Adipose Stem Cell Center at the University of Pittsburgh. Additionally, Dr. Rubin is the primary investigator on an NIH-funded project dedicated to creating cell-based techniques for clinical soft tissue reconstruction following cancer treatment.
Professor Justin M. Sacks, MD, MBA, FACS
Dr. Justin M. Sacks is the Shoenberg Professor and Chief of the Division of Plastic and Reconstructive Surgery in the Department of Surgery at Washington University in St. Louis.
He recently spent the last decade at Johns Hopkins School of Medicine as the Vice-Chair of Clinical Operations and Director of Oncological Reconstruction. Dr. Sacks’s research focuses on advancements in vascularized composite allotransplantation, tissue engineering, and vascular perfusion assessment.
Dr. Sacks’s research interests focus on advancements in tissue engineering, vascularized composite allotransplantation, and vascular perfusion assessment. His clinical interests include reconstructing all forms of acquired, oncological, and traumatic defects ranging from the head and neck to the breast, chest, abdomen, pelvis, and extremities.
Dr. Sack is the co-founder of the Johns Hopkins Biotech Startup Lifesprout. He has authored over 100 original publications in peer-reviewed journals and 20 textbook chapters on plastic surgery and reconstructive surgery. He serves on the editorial board of the Journal of Reconstructive Microsurgery.
He is a fellow of the American College of Surgeons and a member of the American Society of Plastic Surgeons, American Society of Reconstructive Microsurgery, and Plastic Surgery Research Council. He is a founding member of the American Society of Reconstructive Transplantation and the immediate past chair of the Plastic Surgery Research Council.
He recently spent the last decade at Johns Hopkins School of Medicine as the Vice-Chair of Clinical Operations and Director of Oncological Reconstruction. Dr. Sacks’s research focuses on advancements in vascularized composite allotransplantation, tissue engineering, and vascular perfusion assessment.
Dr. Sacks’s research interests focus on advancements in tissue engineering, vascularized composite allotransplantation, and vascular perfusion assessment. His clinical interests include reconstructing all forms of acquired, oncological, and traumatic defects ranging from the head and neck to the breast, chest, abdomen, pelvis, and extremities.
Dr. Sack is the co-founder of the Johns Hopkins Biotech Startup Lifesprout. He has authored over 100 original publications in peer-reviewed journals and 20 textbook chapters on plastic surgery and reconstructive surgery. He serves on the editorial board of the Journal of Reconstructive Microsurgery.
He is a fellow of the American College of Surgeons and a member of the American Society of Plastic Surgeons, American Society of Reconstructive Microsurgery, and Plastic Surgery Research Council. He is a founding member of the American Society of Reconstructive Transplantation and the immediate past chair of the Plastic Surgery Research Council.
Professor Gino Rigotti, MD
Dr. Rigotti is one of the World’s leading plastic and reconstructive surgeons. He is interested in clinical activity and research on autologous lipografting and the action of Adipose Derived Stem Cells. He heads the Lipotech Department (Fat Related Surgical and Clinical Technologies ) at San Francesco Hospital in Verona, Italy.
For the past 15 years, he has been focusing on reconstructive breast surgery using autologous and alloplastic materials. Dr. Rigotti has directed many international courses on Microsurgery, Head, Neck, and Breast Reconstruction.
He has published over 120 articles and chapters in leading international journals and books during his illustrious career. He is in high demand to speak and demonstrate his surgical achievements at global plastic surgery meetings. Dr. Rogotti is a Past President of the International Society of Plastic Regenerative Surgery (ISPRES) and inventor of the widely used Rigottomies 2D and 3D Breast Augmentation/ Reconstruction Technique.
In 2015, the American Society of Plastic Surgery and The Plastic Surgery Foundation presented Dr. Rigotti with the prestigious Jacques W. Maliniac, MD Memorial Lecturer Award.
For the past 15 years, he has been focusing on reconstructive breast surgery using autologous and alloplastic materials. Dr. Rigotti has directed many international courses on Microsurgery, Head, Neck, and Breast Reconstruction.
He has published over 120 articles and chapters in leading international journals and books during his illustrious career. He is in high demand to speak and demonstrate his surgical achievements at global plastic surgery meetings. Dr. Rogotti is a Past President of the International Society of Plastic Regenerative Surgery (ISPRES) and inventor of the widely used Rigottomies 2D and 3D Breast Augmentation/ Reconstruction Technique.
In 2015, the American Society of Plastic Surgery and The Plastic Surgery Foundation presented Dr. Rigotti with the prestigious Jacques W. Maliniac, MD Memorial Lecturer Award.
Professor Peter Vogt, PhD
Professor Vogt is a Professor and Head of the Department of Plastic, Hand and Reconstructive Surgery Burn Center Hannover Medical School, a major national teaching hospital and one of the leading centers for reconstructive surgery focusing on research into regenerative medicine and stem cell therapies.
He is a past President of the German Society for Surgery (2015), the European Burns Association (2013-2015), the German Society of Plastic, Reconstructive and Aesthetic Surgeons (2010–2013), the German Society for Wound Healing and Wound Treatment (2009– 2011), and the German Society for Burn Medicine (2007–2009). He also served as Chief Scientific Officer at The Scripps Research Institute (2012-2015).
He is a past President of the German Society for Surgery (2015), the European Burns Association (2013-2015), the German Society of Plastic, Reconstructive and Aesthetic Surgeons (2010–2013), the German Society for Wound Healing and Wound Treatment (2009– 2011), and the German Society for Burn Medicine (2007–2009). He also served as Chief Scientific Officer at The Scripps Research Institute (2012-2015).
Professor Jaume Masià, MD, PhD
Dr. Màsia is a renowned surgeon currently serving as Chief of the Microsurgery Unit at Sant Pau University Hospital in Barcelona. He is a Professor in Plastic Surgery at Universitat Autonoma de Barcelona, and Director of the Advanced Breast Reconstructive Service and the Integrated Lymphoedema Treatment Unit in Clínica Planas.
Professor Masia is a past President of the Spanish Society of Plastic Surgery and is currently the President of the Spanish Society of Plastic Surgery Foundation for Education.
Since 2010, he has been the Director of the International Master’s Degree on Reconstructive Microsurgery at Universitat Autonoma de Barcelona.
Professor Masia is a past President of the Spanish Society of Plastic Surgery and is currently the President of the Spanish Society of Plastic Surgery Foundation for Education.
Since 2010, he has been the Director of the International Master’s Degree on Reconstructive Microsurgery at Universitat Autonoma de Barcelona.
Professor R. Douglas Macmillan
Mr. Macmillan is a specialist consultant in Cosmetic Breast and Oncoplastic Surgery and leader of the research group in oncoplastic breast surgery at the Nottingham Breast Institute.
He is also a Senior Lecturer in Breast Surgery at the University of Nottingham. Mr. Macmillan is the Director of the International Oncoplastic and Reconstructive Breast Surgery Congress (ORBS). He serves on the Clinical Standards in Breast Cancer Committee with the National Institute for Clinical Excellence (NICE) and the Association of Breast Surgeons Council.
Pilar Matey, LMS, CCST, Hons FRCS
Early adopter and champion, Ms. Matey has been an Oncoplastic Breast Surgeon at the Royal Wolverhampton NHS Trust since January 2001, where she is the lead for breast reconstruction.
She is affiliated with the University Hospital Birmingham and the National Oncoplastic Trainees program, resulting in excellent preparation for professionals in this division of medicine.